AAD 2026Abstract 75315RCT
Quality of Life Improvements in Patients with Genital or Scalp Psoriasis Receiving Risankizumab
16-Week Results from the UnIMMited Randomized Placebo-Controlled Trial
Song EJ, Lewitt GM, Nguyen H, Lyles R, Bialik B, Duan C, Ta R, Ackerman L
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: PsoriasisVulvar & penile
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1448 · Not in PubMed: details from Crossref